Development and Management of Registry in Patients With Gynecologic Cancer in Korea

NCT ID: NCT05912972

Last Updated: 2023-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

13500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-21

Study Completion Date

2027-10-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to identify and analyze the characteristics, treatment trends, prognostic factors and survival prognosis of Korean gynecologic cancer patients. Ultimately, the final goal is to contribute to the development of safe surgical methods and treatment for gynecologic cancer to improve survival rates.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cervical cancer, endometrial cancer, and ovarian cancer represent gynecologic cancers. There are many open issues that need to be addressed, specifically the surgical method, disease recurrence and survival outcome in the so called "real world" setting. The aim of this observational study is to collect both retrospective and prospective medical information of gynecologic cancer patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Cancer Endometrial Cancer Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cervical cancer

No interventions

Patient registry

Intervention Type OTHER

Clinical data, specific procedures and treatments will follow the Institutional standard operative procedures

Endometrial cancer

No interventions

Patient registry

Intervention Type OTHER

Clinical data, specific procedures and treatments will follow the Institutional standard operative procedures

Ovarian cancer, Fallopian tube cancer, Peritoneal cancer

No interventions

Patient registry

Intervention Type OTHER

Clinical data, specific procedures and treatments will follow the Institutional standard operative procedures

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient registry

Clinical data, specific procedures and treatments will follow the Institutional standard operative procedures

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female patients 18 years or older
* Written informed consent (prospective cohort)
* Confirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer

Exclusion Criteria

* Unconfirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asan Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jeong-Yeol Park, MD, PhD

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeong-Yeol Park, PhD

Role: PRINCIPAL_INVESTIGATOR

Asan Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jeong-Yeol Park, PhD

Role: CONTACT

+82230103646

So Hyun Nam, MD

Role: CONTACT

+82230100869

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jeong-Yeol Park, M.D., Ph.D.

Role: primary

+82230103646

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-1412

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sentinel Lymph Nodes Biopsy in Cervical Cancer
NCT06169787 ACTIVE_NOT_RECRUITING